Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-blind, Placebo-controlled Trial

DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Primary tabs

Tombal, Bertrand [UCL]

Lecouvet, Frédéric [UCL]

Comment on "Dutasteride in localised prostate cancer management: the REDEEM randomised, double-blind, placebo-controlled trial. [Lancet. 2012]"

Document type	Article de périodique (Journal article) – Article de recherche
Access type	Accès restreint
Publication date	2012
Language	Anglais
Journal information	"European Urology" - Vol. 61, no. 6, p. 1265-1266 (2012)
Peer reviewed	yes
Publisher	Elsevier BV ((Netherlands) Amsterdam)
issn	0302-2838
e-issn	1421-993X
Publication status	Publié
Affiliations	UCL - SSS/IREC/IMAG - Pôle d'imagerie médicale UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation UCL - (SLuc) Service de radiologie UCL - (SLuc) Service d'urologie
Links	http://hdl.handle.net/2078.1/125138[Handle] http://www.ncbi.nlm.nih.gov/pubmed/22542091[Pubmed] https://doi.org/10.1016/j.eururo.2012.03.028[DOI]

Bibliographic reference	Tombal, Bertrand ; Lecouvet, Frédéric. Re: Dutasteride in Localised Prostate Cancer Management: The REDEEM Randomised, Double-blind, Placebo-controlled Trial. In: European Urology, Vol. 61, no. 6, p. 1265-1266 (2012)
Permanent URL	http://hdl.handle.net/2078.1/125138